Further Decision Processed by IB
03/05/2025
Voltar para busca
Dado oficial do USPTO
CYTOTUNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
04/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
02/07/2010
Data de registro
07/02/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/07/2022
Última transação
04/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Tsukuba-shi Ibaraki, JP
Examinador
DE JONGE, KATHLEEN
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
ID Pharma Co., Ltd.
D. C. (pessoa física)
Representantes
Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicalspolypeptides for in vitro and in vivo scientific and research use; biochemicalspolynucleotides for in vitro and in vivo scientific and research use ; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific researchreagentscosmeticspharmaceuticals
Classe 5
Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancercritical limb ischemiacystic fibrosisretinitis pigmentosaAIDSinfluenzaAlzheimer's disease; preparations for gene therapyintroducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical usefor gene therapy
Classe 42
Testinginspectionresearchdevelopment of pharmaceuticalscosmeticsfoodstuff; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; testinginspectionresearchdevelopment of vaccines; testinginspectionresearchdevelopment of recombinant proteins; medicalchemicalbiochemicalbiological and bacteriological research and functional analysis of genes or proteins; testinginspectionresearch related to technologies for manufacturing genetically engineered animalsplantsvectors; testinginspectionresearchdevelopment of vector technologiesmedical and scientific research in the field of genetics and genetic engineering; testinginspectionresearch on agriculturelivestock breedingfisheries; testinginspectionresearchdevelopment of chemicals for life science
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/03/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/03/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
07/03/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/03/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
13/07/2022
71AG
REGISTERED-SEC.71 ACCEPTED
13/07/2022
ES71
TEAS SECTION 71 RECEIVED
11/07/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/02/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
14/09/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/05/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19/03/2019
INPC
INVALIDATION PROCESSED
19/03/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/03/2019
RFNP
REFUSAL PROCESSED BY IB
05/01/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
13/07/2018
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
13/07/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/07/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
18/06/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/02/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/10/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/07/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/07/2012
FIMP
FINAL DISPOSITION PROCESSED
06/07/2012
GPNX
NOTIFICATION PROCESSED BY IB
30/06/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/11/2011
PUBO
PUBLISHED FOR OPPOSITION
22/11/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/11/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/10/2011
ATRV
ATTORNEY REVIEW COMPLETED
18/10/2011
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
17/10/2011
ALIE
ASSIGNED TO LIE
13/10/2011
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/10/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/09/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2011
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/09/2011
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/09/2011
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/09/2011
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
01/06/2011
GNSF
SUBSEQUENT FINAL EMAILED
01/06/2011
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
01/06/2011
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/06/2011
GNFR
FINAL REFUSAL E-MAILED
01/06/2011
CNFR
FINAL REFUSAL WRITTEN
01/06/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/05/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2011
RFNT
REFUSAL PROCESSED BY IB
18/12/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/11/2010
RFRR
REFUSAL PROCESSED BY MPU
30/11/2010
MAFR
APPLICATION FILING RECEIPT MAILED
30/11/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/11/2010
CNRT
NON-FINAL ACTION WRITTEN
28/11/2010
DOCK
ASSIGNED TO EXAMINER
26/11/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/11/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/11/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CYTOTUNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.